A/Prof Ezharul Hoque Chowdhury from Monash University’s Jeffrey Cheah School of Medicine and Health Sciences Malaysia campus is keen to collaborate with MPCCC researchers, who might have interests in using smart nanoparticles for therapeutic delivery in animal models.
“We have found the nanoparticles hold high potential based on current experimental data in an animal model of breast cancer. The system could be used to deliver small molecule as well as macromolecular drugs to tumor, brain and other organs” said A/Prof Chowdhury.
A/Prof Chowdhury pioneered the development of carbonate apatite as a smart tool for efficient and targeted intracellular delivery of genetic materials, gene-silencing elements, proteins and classical anti-cancer drugs. He has created a new branch of nanomedicine delivery based on this pH-sensitive inorganic nano-carrier. His research team is one of the leading groups in the world working in the relevant area. His outstanding contributions have so far produced over 50 publications in the highly cited journals and 5 Japanese and US patents, some of which have already being commercialized.